Plasmid-mediated TEM-3 extended-spectrum β-lactamase production in Salmonella typhimurium in Casablanca

被引：41

作者：

AitMhand, R

Soukri, A

Moustaoui, N

Amarouch, H

ElMdaghri, N

Sirot, D

Benbachir, M

机构：

[1] IbnRochd Univ Hosp, Casablanca, Morocco

[2] Fac Sci I AinChock, Casablanca, Morocco

[3] Fac Med Clermont Ferrand, Clermont Ferrand, France

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 49卷 / 01期

关键词：

D O I：

10.1093/jac/49.1.169

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Isolates of extended-spectrum beta-lactamase (ESBL)-producing Salmonella typhimurium were recovered from children admitted to the IbnRochd University Hospital of Casablanca in 1994. These isolates produced TEM-3 as shown by PCR, isoelectric focusing and sequencing. Production of TEM-3 and resistance to gentamicin were encoded by a 10 kb plasmid that could be transferred by conjugation and transformation. This report extends the list of ESBLs produced by S. typhimurium and stresses the need for continuous surveillance of non-typhoidal Salmonella to adapt antibiotic treatment and preventive measures.

引用

收藏

页码：169 / 172

页数：4

相关论文

共 17 条

[1]

AITMHAND R, 1999, J CLIN MICROBIOL, V37, P3769

[2] POSSIBLE INVIVO TRANSFER OF BETA-LACTAMASE TEM-3 FROM KLEBSIELLA-PNEUMONIAE TO SALMONELLA-KEDOUGOU [J].

ARCHAMBAUD, M ;

GERBAUD, G ;

LABAU, E ;

MARTY, N ;

COURVALIN, P .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (04) :427-436

[3] IN-VIVO ACQUISITION OF EXTENDED-SPECTRUM BETA-LACTAMASE IN SALMONELLA-ENTERITIDIS DURING ANTIMICROBIAL THERAPY [J].

BARGUELLIL, F ;

BURUCOA, C ;

AMOR, A ;

FAUCHERE, JL ;

FENDRI, C .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (08) :703-706

[4] Characterization of beta-lactamase gene bla(PER-2,) which encodes an extended-spectrum class A beta-lactamase [J].

Bauernfeind, A ;

Stemplinger, I ;

Jungwirth, R ;

Mangold, P ;

Amann, S ;

Akalin, E ;

Ang, O ;

Bal, C ;

Casellas, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :616-620

[5] A NEW PLASMIDIC CEFOTAXIMASE FROM PATIENTS INFECTED WITH SALMONELLA-TYPHIMURIUM [J].

BAUERNFEIND, A ;

CASELLAS, JM ;

GOLDBERG, M ;

HOLLEY, M ;

JUNGWIRTH, R ;

MANGOLD, P ;

ROHNISCH, T ;

SCHWEIGHART, S ;

WILHELM, R .

INFECTION, 1992, 20 (03) :158-163

[6]

BENREDJEB S, 1988, J ANTIMICROB CHEMOTH, V21, P263

[7] A STRAIN OF SALMONELLA-PANAMA PRODUCING A BROAD-SPECTRUM BETA-LACTAMASE IN FORT-DE-FRANCE (MARTINIQUE) [J].

CABIE, A ;

JOUANNELLE, J ;

SAINTAIME, C .

MEDECINE ET MALADIES INFECTIEUSES, 1989, 19 (8-9) :418-420

[8] Survey of prevalence of extended spectrum beta-lactamases among Enterobacteriaceae [J].

Chanal, C ;

Sirot, D ;

Romaszko, JP ;

Bret, L ;

Sirot, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) :127-132

[9] SALMONELLA-TYPHI INVIVO ACQUIRES RESISTANCE TO BOTH CHLORAMPHENICOL AND CO-TRIMOXAZOLE [J].

DATTA, N ;

RICHARDS, H ;

DATTA, C .

LANCET, 1981, 1 (8231) :1181-1183

[10] Two novel plasmid-mediated cefotaxime-hydrolyzing β-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium [J].

Gazouli, M ;

Tzelepi, E ;

Markogiannakis, A ;

Legakis, NJ ;

Tzouvelekis, LS .

FEMS MICROBIOLOGY LETTERS, 1998, 165 (02) :289-293